Similarly, we have previously reported that cancer cell expression of the co-inhibitory immune checkpoint molecules PDL-1 and HHLA-2 is more prevalent in ampullary cancer patients than in pancreatic cancer patients (p=0.043) (50). This evidence concerns the gene HHLA2 and carcinoma of the ampulla of vater.